The pandemic has demonstrated that very few companies are completely immune to large-scale disruptions. Indeed, several companies in the luxury goods sector suffered falls in their sales. But thanks to a number of unique factors, the luxury goods sector was not quite so hard-hit as many others were.

  Strategic Insights | Bio-Technology     Covid-19 and biotech   By the time Covid-19 is done with us, the global economic landscape will have changed almost beyond recognition. The high street is being decimated as BigTech cleans up, and biotech innovators are leading the charge against coronavirus. Buying biotechnology funds therefore seems like an […]